Efficacy of Lurasidone in Adults Aged 55 Years and Older With Bipolar Depression: Post Hoc Analysis of 2 Double-Blind, Placebo-Controlled Studies
The DOI matches its Crossref record.
Abstract
OBJECTIVE: The aim of this post hoc analysis was to evaluate the efficacy of lurasidone in patients aged 55 years and older with bipolar depression. METHODS: A post hoc analysis was performed on the older adult subgroup (n = 142) of outpatients meeting DSM-IV-TR criteria for bipolar I depression in 2 placebo-controlled, 6-week, randomized, double-blind studies conducted from 2009-2012: a monotherapy study comparing fixed flexible-dose ranges of lurasidone 20-60 mg/d or 80-120 mg/d with placebo and an adjunctive therapy study comparing flexible doses of lurasidone 20-120 mg/d with placebo adjunctive to either lithium or valproate. The primary endpoint was mean change at week 6 in the Montgomery-Åsberg Depression Rating Scale (MADRS) total score. RESULTS: In the randomized sample, the proportion of older adults was 88/505 (17.4%) in the monotherapy study and 54/348 (15.5%) in the adjunctive therapy study. In the older adult subgroup in the monotherapy study, mean change at week 6 in the MADRS was significantly greater for lurasidone versus placebo (-14.8 vs -7.1; P = .003; effect size, 0.83; pooled doses), and in the adjunctive therapy study, mean change for lurasidone was not significantly different from placebo (-13.9 vs -11.1; P = .398; effect size, 0.26). Discontinuation rates due to adverse events for lurasidone versus placebo were similar for the monotherapy (6.8% vs 6.9%) and adjunctive therapy (3.8% vs 7.1%) studies. Lurasidone had minimal effects on metabolic laboratory values. CONCLUSIONS: The results of these post hoc analyses, which assessed the efficacy of lurasidone in older adults with bipolar disorder, found that monotherapy was significantly effective while adjunctive therapy was not associated with significant improvement. Both monotherapy and adjunctive therapy with lurasidone were safe and well-tolerated in this older adult population. TRIAL REGISTRATION: ClinicalTrials.gov identifiers: NCT00868699, NCT00868452.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Post hoc analyses of RCTs suggest efficacy of quetiapine (level 2)661 and lurasidone (level 2)662 monotherapy and hence these are recommended as first‐line options.”
Citations
Cites
Still being checked.
Cited by
Yatham, L. N., Kennedy, S. H., Parikh, S. V., Schaffer, A., Bond, D. J., Frey, B. N., Sharma, V., Goldstein, B. I., Rej, S., Beaulieu, S., et al. (2018) · Bipolar Disorders · doi:10.1111/bdi.12609 · Cited by 1,852
Old Age Bipolar Disorder—Epidemiology, Aetiology and Treatment
Arnold, I., Dehning, J., Grunze, A., & Hausmann, A. (2021) · Medicina · doi:10.3390/medicina57060587 · Cited by 85
Using Lithium in Older Age Bipolar Disorder: Special Considerations
Soh, J. F., Klil‐Drori, S., & Rej, S. (2019) · Drugs & Aging · doi:10.1007/s40266-018-0628-1 · Cited by 63
Treatment of bipolar disorders in older adults: a review
Ljubic, N., Ueberberg, B., Grunze, H., & Assion, H. (2021) · Annals of General Psychiatry · doi:10.1186/s12991-021-00367-x · Cited by 62
Okubo, R., Hasegawa, T., Fukuyama, K., Shiroyama, T., & Okada, M. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.623684 · Cited by 55
Treatments for Schizophrenia in Adults: A Systematic Review
McDonagh, M. S., Dana, T., Selph, S., Devine, E. B., Cantor, A. G., Bougatsos, C., Blazina, I., Grusing, S., Fu, R., Kopelovich, S. L., et al. (2017) · doi:10.23970/ahrqepccer198 · Cited by 54
Lithium, the gold standard drug for bipolar disorder: analysis of current clinical studies
Airainer, M., & Seifert, R. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03210-8 · Cited by 40
Shobassy, A. (2021) · Current Psychiatry Reports · doi:10.1007/s11920-020-01216-6 · Cited by 42
Therapeutic Potential and Limitation of Serotonin Type 7 Receptor Modulation
Fukuyama, K., Motomura, E., & Okada, M. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032070 · Cited by 36
Okada, M., Matsumoto, R., Yamamoto, Y., & Fukuyama, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031351 · Cited by 34
Lurasidone: efficacy and safety in the treatment of psychotic and mood disorders
Pompili, M., Verzura, C., Trovini, G., Buscajoni, A., Falcone, G., Naim, S., Nardella, A., Sorice, S., Baldessarini, R. J., & Girardi, P. (2017) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2017.1379989 · Cited by 30
Vasudev, A., Chaudhari, S., Sethi, R., Fu, R., Sandieson, R. M., & Forester, B. P. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0579-6 · Cited by 30
Self-citationMaruki, T., Utsumi, T., Takeshima, M., Fujiwara, Y., Matsui, M., Aoki, Y., Toda, H., Watanabe, N., Watanabe, K., & Takaesu, Y. (2022) · International Journal of Bipolar Disorders · doi:10.1186/s40345-022-00271-7 · Cited by 19
Forester, B. P., Sajatovic, M., Tsai, J., Pikalov, A., Cucchiaro, J. B., & Loebel, A. D. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.08.013 · Cited by 17
Self-citationAdvances in the psychopharmacotherapy of bipolar disorder type I
Sleem, A., & El‐Mallakh, R. S. (2021) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2021.1893306 · Cited by 16
Evaluating lurasidone as a treatment option for bipolar disorder
Ali, Z., Tegin, C., & El‐Mallakh, R. S. (2020) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2019.1695777 · Cited by 16
Evaluation and treatment of older-age bipolar disorder: a narrative review
Tampi, R. R., Joshi, P., Bhattacharya, G., & Gupta, S. (2021) · Drugs in Context · doi:10.7573/dic.2021-1-8 · Cited by 17
Bipolar Disorder Among Older Adults: Newer Evidence to Guide Clinical Practice
Dols, A., Sekhon, H., Rej, S., Klaus, F., Bodenstein, K., & Sajatovic, M. (2023) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.20230010 · Cited by 15
Self-citationThe spectrum of bipolar disorder in older adults
Eyler, L. T., Klaus, F., Dyne, A. V., Ng, H. X., Dols, A., & Sajatovic, M. (2026) · Neuropsychopharmacology · doi:10.1038/s41386-026-02330-4 · Cited by 6
Self-citationGarel, N., Dols, A., Yu, J., Cresce, C. D., Rej, S., & Sajatovic, M. (2025) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2024.12.006 · Cited by 6
Self-citationBurton, C. E., Mathys, M. L., & Gutierrez, E. (2021) · Psychiatry Research · doi:10.1016/j.psychres.2021.114063 · Cited by 6
Zou, X., Yang, Y., Yue, B., Yang, H., Yang, Y., Li, M., Du, O., Qiao, G., Wu, Y., Du, J., et al. (2025) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.70455 · Cited by 5
Treatment of Bipolar Disorders in Older Adults: A Review
Ljubic, N., Ueberberg, B., Grunze, H., & Assion, H. (2023) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.23021024 · Cited by 7
Lurasidone Treatment for Delusional Infestation in a Patient with Dementia
Her, Y., Chang, H., Wan, F.-J., & Tzeng, N. (2023) · Journal of Medical Sciences · doi:10.4103/jmedsci.jmedsci_410_20 · Cited by 3
Clinical Management of Older Age Bipolar Disorder
Dols, A., Chan, M. Y. S., & Shulman, K. I. (2017) · Springer eBooks · doi:10.1007/978-3-319-48912-4_4 · Cited by 3
Renal Concerns Relative to the Use of Lithium in Geriatric Bipolar Disorder Patients
Szpunar, J., Maeshima, H., & Grossberg, G. T. (2017) · Annals of Clinical Psychiatry · doi:10.1177/104012371702900410 · Cited by 2
Cariprazine for late-life psychiatric illness: A review on therapeutic potential and challenges
Mukku, S. S. R., Nadella, R. K., & Kornapalli, S. E. (2021) · Journal of Geriatric Mental Health · doi:10.4103/jgmh.jgmh_43_21 · Cited by 2
Pharmacological Treatment of Bipolar Disorder in the Elderly
Katz, T. C., Georgakas, J. E., Motyl, C. M., Quayle, W., & Forester, B. P. (2017) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0101-5 · Cited by 2
Self-citationTreatment of Schizophrenia and Psychoses in Older Adults: Psychopharmacological Approaches
Madhusoodanan, S., & Coleman, A. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108539593.014 · Cited by 2
Aga, V. M., Shad, M. U., Zhu, H., & Salzman, C. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-800136-3.00023-5 · Cited by 3
Mood Stabilizers: Course and Duration of Therapy, Withdrawal Syndromes, and Resistance to Therapy
Schoretsanitis, G., & Paulzen, M. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_39 · Cited by 2
Chapter 20. Psychopharmacology
Mulsant, B. H., & Pollock, B. G. (2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375196.ds20 · Cited by 1
Asir, B., Al‐Soleiti, M., & Singh, B. (2026) · Drugs & Aging · doi:10.1007/s40266-026-01315-8 · Cited by 1
Mood Stabilizers: Course and Duration of Therapy, Withdrawal Syndromes, and Resistance to Therapy
Schoretsanitis, G., & Paulzen, M. (2019) · Springer eBooks · doi:10.1007/978-3-319-56015-1_39-1 · Cited by 1
A Comprehensive Review of the Evaluation, Diagnosis, and Treatment of Older Adult Bipolar Disorder
Patrick, R. E., Heintz, H., Skurla, M. D., & Forester, B. P. (2020) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-020-00232-w · Cited by 1
Self-citationAhearn, E. P., Chen, P., & Sajatovic, M. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819182-8.00031-4 · Cited by 3
Self-citationChue, P. S., & Siraki, A. G. (2017) · Side effects of drugs annual · doi:10.1016/bs.seda.2017.06.029 · Cited by 1
Lurasidone: A New Option for Older Adults with Bipolar Disorder?
Rej, S. (2017) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2017.09.003 · Cited by 1
Current Pharmacotherapies in Older Age Bipolar Disorder
Moussaoui, G., Amsterdam, J. V., Soh, J. F., Torres-Platas, S. G., & Rej, S. (2017) · Current Treatment Options in Psychiatry · doi:10.1007/s40501-017-0132-y
Depressive Disorders and Bipolar and Related Disorders
Tampi, R. R., Tampi, D. J., Walters, M. I., Manikkara, G., Alag, P., & Garg, G. (2018) · Springer eBooks · doi:10.1007/978-3-319-73078-3_17
Psychotropic Drug Treatment in Later Life
Davies, S. (2020) · Cambridge University Press eBooks · doi:10.1017/9781911623465.020 · Cited by 1
Neto, H. P. D. Q., Marinho, A. O. D. O., Barroso, M. L., Quaresma, F. E. D. L., & Cabral, S. A. A. D. O. (2021) · ID on line REVISTA DE PSICOLOGIA · doi:10.14295/idonline.v15i55.3044 · Cited by 1
Lurasidone: Ten Years Treating Adults with Bipolar Depression
Albuquerque, M., Facucho-Oliveira, J., Esteves-Sousa, D., Moura, N., Neto, D., & Cintra, P. (2021) · Revista Portuguesa de Psiquiatria e Saúde Mental · doi:10.51338/rppsm.2021.v7.i2.199
Hoq, R. (2021) · Springer eBooks · doi:10.1007/978-3-030-58663-8_28
Almeida, O. P., Dols, A., & Sajatovic, M. (2019) · Cambridge University Press eBooks · doi:10.1017/9781108593946.012
Self-citationKorean Medication Algorithm Project for Bipolar Disorder 2022: The Elderly
Choo, I. H., Bahk, W., Woo, Y. S., Jeong, J., Yoon, B.-H., Seo, J. S., Yang, C.-M., Kim, W., Lee, J. G., Shim, S.-H., et al. (2022) · 신경정신의학 · doi:10.4306/jknpa.2022.61.4.261
Chapter 10. Bipolar and Related Disorders
Beyer, J. L. (2022) · American Psychiatric Association Publishing eBooks · doi:10.1176/appi.books.9781615375196.ds10
Tampi, R. R., & Tampi, D. J. (2024) · Springer eBooks · doi:10.1007/978-3-031-55711-8_10 · Cited by 1
Psychotic Symptoms and Syndromes
Smith, W. B., Ureste, P. J., DeFries, C. C., & Seritan, A. L. (2024) · Springer eBooks · doi:10.1007/978-3-031-53976-3_9
Trouble bipolaire chez la personne âgée
Schuster, J., Manetti, A., Gervais, A., & Limosin, F. (2023) · Elsevier eBooks · doi:10.1016/b978-2-294-77180-4.00016-0
Maruki, T., Utsumi, T., Takeshima, M., Fujiwara, Y., Matsui, M., Aoki, Y., Toda, H., Watanabe, N., Watanabe, K., & Takaesu, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21383114
Maruki, T., Utsumi, T., Takeshima, M., Fujiwara, Y., Matsui, M., Aoki, Y., Toda, H., Watanabe, N., Watanabe, K., & Takaesu, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21383117
Maruki, T., Utsumi, T., Takeshima, M., Fujiwara, Y., Matsui, M., Aoki, Y., Toda, H., Watanabe, N., Watanabe, K., & Takaesu, Y. (2022) · Figshare · doi:10.6084/m9.figshare.21383111
Wang, L., Xue, H., Fu, T., Gong, X., Zhu, R., Duan, J., Pan, C., Zhou, J., Lin, Z., Du, W., et al. (2026) · International Journal of Bipolar Disorders · doi:10.1186/s40345-026-00421-1
Expert Consensus on the Use of Lurasidone for Bipolar I Depression in Asian Patients
Sulaiman, A. H., Chui, M.-C. E., Kongsakon, R., Lee, J. P., Lin, C., Ng, B. Y., Tan, M. W. L., Ting, J. H., & Idris, M. H. M. (2026) · ALPHA PSYCHIATRY · doi:10.31083/ap49358
Metadata
- Authors
- Sajatovic, M., Forester, B. P., Tsai, J., Kroger, H., Pikalov, A., Cucchiaro, J., & Loebel, A.
- Affiliations
- University Hospitals Cleveland Medical Center (US)
- Harvard University (US)
- Sunovion (United States) (US)
- Corresponding author
- Sajatovic, Martha
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2016-08-16
- Volume
- 77
- Issue
- 10
- Pages
- e1324-e1331
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2514389710
- Cited by
- 54
- References
- 0
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 3 · 2023: 5 · 2022: 8 · 2021: 12 · 2020: 5 · 2019: 4 · 2018: 3 · 2017: 8
- FWCI
- 4.45
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- lurasidone, bipolar depression, bipolar I disorder, older adults, monotherapy, adjunctive therapy, lithium, valproic acid, antidepressant efficacy, drug safety and tolerability
- MeSH terms
- Lurasidone Hydrochloride, Aged, Bipolar Disorder, Dose-Response Relationship, Drug, Double-Blind Method, Drug Administration Schedule, Drug Therapy, Combination, Female, Humans, Male, Middle Aged, Valproic Acid, Lithium Carbonate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.